Peers

Morepen Laboratories Ltd. shows moderate growth and strong financial health compared to its peers. While it has the lowest debt levels, its profitability metrics are lower than those of top performers in the sector. Companies like Cipla and Dr. Reddy's Laboratories exhibit superior profitability and growth, positioning them as sector leaders, while Divi's Laboratories and Sun Pharmaceutical Industries appear overvalued given their high PE ratios.

• • Morepen Laboratories has low debt levels (0.0342) compared to peers.
• • Cipla and Dr. Reddy's have the highest profitability metrics with ROE of 16.63% and 21.76% respectively.
• • Divi's Laboratories shows negative revenue growth over three years, indicating financial weakness.

• • Cipla Ltd.: Highest ROE (16.63%) and significant revenue growth (YoY 13.28%).
• • Dr. Reddy's Laboratories Ltd.: Strong profitability with an ROE of 21.76% and high growth trajectory.
• • Mankind Pharma Ltd.: Outstanding revenue growth of 18.12% YoY and strong profitability metrics.